| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |